[{"orgOrder":0,"company":"GenomeFrontier Therapeutics","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"TAIWAN","productType":"Undisclosed","year":"2024","type":"Inapplicable","leadProduct":"GF-CART01","moa":"CD19","graph1":"Oncology","graph2":"Phase I","graph3":"GenomeFrontier Therapeutics","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"GenomeFrontier Therapeutics \/ Inapplicable","highestDevelopmentStatusID":"6","companyTruncated":"GenomeFrontier Therapeutics \/ Inapplicable"}]
Find Clinical Drug Pipeline Developments & Deals by GenomeFrontier Therapeutics
Filters
×
FILTER:
Company Name
Year
DEALS // DEV.
Country
Sponsor
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Reset All
